2026-05-17T05:43:32Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/202702024-11-29T04:34:30Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967

00925njm 22002777a 4500 dc Arranz Izquierdo, Javier author Lundeby, Karen Marie author Hassan, Shoaib author Zabala Fuentes, Luis Matias author San Jose Garces, Pedro author Haaskjold, Yngvar Lunde author Bolkan, Hakon Angell author Krogh, Kurt Osthuus author Jongopi, James author Mellesmo, Sindre author Josendal, Ola author Opstad, Asmund author Svensen, Erling author Kamara, Alfred Sandy author Roberts, David P author Stamper, Paul D author Austin, Paula author Moosa, Alfredo J author Marke, Dennis author Berg, Ase author Blomberg, Bjorn author Riera, Melchor author 2016-06-22 Background: The last ebola virus disease (EVD) outbreak has been the most important since 1976. EVD cases decreased drastically in Sierra Leone at the beginning of 2015. We aim to determine the clinical findings and evolution of patients admitted to an Ebola treatment center (ETC) during the epidemic's late phase. Methods: We analyze retrospectively data of patients admitted to the Moyamba ETC (December 2014-March 2015). Patients were classified in EVD or non-EVD patients according to the results of Ebola virus real-time reverse transcription polymerase chain reaction (ZAIRE-RT-PCR). Results: Seventy-five patients were included, 41.3 % were positive for ZAIRE-RT-PCR. More women (68 % vs 28 %, p = 0.001) were EVD-positive. More EVD patients had previous contact with an Ebola patient (74.2 % vs 36.3 %, p < 0. 001). At admission, EVD patients were more likely to have fatigue (96.7 %, p < 0.001), diarrhea (67.7 %, p = 0.002), and muscle pain (61.3 %, p = 0.009); but only objective fevers in 35.5 % of EVD patients. The most reliable criteria for diagnosis were: contact with an Ebola patient plus three WHO symptoms (LR+ = 3.7, 95 % CI = 1.9-7.3), and positive contact (LR+ = 2.3, 95 % CI = 1.15-4.20). Only 45.2 % of EVD patients developed fevers during stay, but 75 % developed gastrointestinal symptoms. Non-EVD patients had gastrointestinal problems (33 %), respiratory conditions (26.6 %), and others such as malaria, HIV or tuberculosis with a mortality rate of 11.4 %. vs 58 % in EVD group (p < 0.001). Conclusions: More non-EVD patients were admitted in the outbreak's late phases. The low percentage of initial fever highlights the need to emphasize the epidemiological information. EVD patients presented new symptoms getting worse and requiring closer follow-up. Diagnoses of non-EVD patients were diverse with a remarkable mortality, presenting a challenge for the health system. Arranz J, Lundeby KM, Hassan S, Zabala Fuentes LM, San Jose Garces P, Haaskjold YL, et al. Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak. BMC Infect Dis. 2016 Jun 22;16:308. 10.1186/s12879-016-1609-9 1471-2334 BMC Infectious Diseases http://hdl.handle.net/20.500.13003/10300 27334891 L610868934 2-s2.0-84975259885 http://hdl.handle.net/20.500.12105/20270 378587400001 Ebola virus disease (EVD) Sierra Leone Clinical features of suspected Ebola patients Diagnostic validation Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak